Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Health Canada approves obesity drug Wegovy
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js
Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish drugmaker said on Wednesday.
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
A dose of four Wegovy injections will cost 1,400 yuan ($194), a fraction of the drug’s U.S. price, according to the Chinese website Yicai. However, patients in China will have to pay out of pocket for the treatment, as it is not yet covered by the national healthcare insurance, João da Silva of BBC reported.
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Health Canada approves Wegovy(R) (semaglutide injection) to reduce the risk of non-fatal myocardial infarction
Wegovy(R) is the first-and-only medication indicated for both chronic weight management and to reduce the risk of non-fatal myocardial infarction (MI) in Canada.1 -- Close to one in three Canadian adults are living with obesity,
Health Matters: Wegovy approved to reduce heart attack risk
Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
Health Canada approves obesity drug Wegovy as a way to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
The Economist
11h
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Wall Street Journal on MSN
2d
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction
The Biden administration on Tuesday proposed that weight-loss drugs be paid for by Medicaid and Medicare, potentially making ...
3d
Exclusive-Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
1d
on MSN
Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
2d
on MSN
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
2d
Novo Nordisk: Supply Strains, Competition, And RFK Concerns Mask Solid Fundamentals
Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...
Bloomberg L.P.
3d
Novo Nordisk Foundation Targets US, Europe After Obesity Boost
The
Novo
Nordisk
Foundation’s assets have swelled with the success of diabetes and obesity treatments Ozempic and ...
2d
on MSN
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
2d
on MSN
Novo Nordisk Is Scaling Back Its Hiring Spree in Denmark
Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Joe Biden
China
Medicare
CagriSema
Feedback